Esketamine floats past adcom vote - Vantage

Submitted by Anonymous (not verified) on Wed, 02/13/2019 - 12:00

Esketamine floats past adcom vote  VantageJohnson & Johnson's esketamine should get approved in depression, but a safety plan requiring supervision raises questions about its commercial promise.